Search results
Abbott Snags U.S. Clearance To Enter The Obesity Arena, Rivaling Dexcom
Investor's Business Daily· 2 hours agoAbbott stock inched ahead a fraction in premarket trading on today's stock market. Shares leapt over...
Waterloo Capital L.P. Buys Shares of 6,623 Abbott Laboratories (NYSE:ABT)
ETF DAILY NEWS· 1 day agoWaterloo Capital L.P. purchased a new position in Abbott Laboratories (NYSE:ABT – Free Report) in the 4th quarter, according to the company in its most ...
Insider Selling: Funck, Jr. Robert E., Abbott Laboratories [ABT] EXECUTIVE VICE PRESIDENT divested...
Knox Daily· 3 days agoAnalysts at Wolfe Research...the last five days, there has been a surge of approximately 2.49%. Over the course of the year, Abbott Laboratories shares have dropped approximately ...
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
Zacks via Yahoo Finance· 5 days agoThe Zacks Medical - Products industry, to which Abbott belongs, has gained 0.6% over this period....
Abbott (ABT) Is Considered a Good Investment by Brokers: Is That True?
Zacks· 4 days agoAbbott currently has an average brokerage recommendation (ABR) of 1.50, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual ...
Abbott (ABT) Stock Dips While Market Gains: Key Facts
Zacks via Yahoo Finance· 5 days agoRecent revisions tend to reflect the latest near-term business trends. As such, positive estimate...
Abbott Laboratories may have misled diabetic customers
Courthouse News Service· 4 days agoU.S. District Judge P. Casey Pitts ordered this week to allow most class false advertising claims to...
Chemours Company [CC] Investment Guide: What You Need to Know – Knox Daily
Knox Daily· 6 days agoAs a result of the transaction, Abbott Matthew S now holds 29,869 shares, worth roughly $0.73 million. BMO Capital Markets upgraded its Chemours Company ...
Is Abbott Laboratories (NYSE:ABT) the Best Value Dividend Aristocrat Stock?
Insider Monkey via Yahoo Finance· 4 days agoWe recently compiled the list of 25 Best Dividend Aristocrats Stocks According to Analysts. Since ...
DexCom (DXCM) Declines on Potential Competition for Stelo (revised)
Zacks· 6 days agoThe FDA approval for Stelo in March 2024 looked promising as it was the first and only continuous...